Alamar Biosciences, Inc. SEC filings
Alamar Biosciences filed 8 documents with the SEC in the last twelve months, the latest report being the 10-Q of 11 August 2026. The latest filing, on 1 September 2026, was an 8-K: officer or director change.
New to this? How to read this page
- Companies file with the SEC when something happens. 10-Q and 10-K are the quarterly and annual reports; 8-K is news that cannot wait for the next report.
- An 8-K says which items it covers, such as results, a change at the top or a big contract. A foreign company files a 6-K instead.
- The results release is usually an 8-K filed the day results come out, before the 10-Q or 10-K.
- Every filing links to the original on EDGAR, the SEC's own site.
Twelve months of filings
by kindMost of the filings were other company news (3). Results came out 2 times.
Each mark is one filing on the day it was filed, in rows by kind. Hover or tap a mark for the form and what it was about.
The share price around each results release
close before to close afterOver the last 2 releases the share price moved 14.7% on average in the two days around results, the most on 10 Aug 2026 (+28.5%).
Each ring marks a results filing. The move runs from the last close before the filing to the first close after it, so it covers results released before the open or after the close. Hover the line for any day's close.
What the company told investors on 8-K
5 filingsAlamar Biosciences's 5 news filings (8-K) were mostly about results of operations (2) and other events (2).
- Results of operationsThe quarterly results release2 · latest 10 Aug 2026
- Other eventsNews the company chose to file2 · latest 15 Jul 2026
- Officer or director changeSomeone joined, left or changed role at the top1 · latest 1 Sep 2026
- Charter or bylaw amendment, or fiscal year changeThe company's rules or fiscal year changed1 · latest 20 Apr 2026
Each line is one kind of news, with what it means in plain words. Each square is one filing; a filing can carry more than one kind, so the squares can add up to more than the filings. The date opens the latest one on EDGAR.
How it compares
every company on the siteThe bar ranks every company on the site from the lowest on the left to the highest on the right, in three equal thirds; the small figures under it are the values where each third starts, and the black tick is the middle company. The orange dot is this company; the grey ticks are the other companies in its industry (hover or tap for names). A hatched block is companies tied at none.
Every filing as a table
In the last twelve months Alamar Biosciences, Inc. filed 8 documents with the SEC of the kinds listed here: 5 current reports (8-K), about 2 results of operations; 2 other events; 1 officer or director change; 1 charter or bylaw amendment, or fiscal year change; 2 quarterly reports (10-Q), 1 employee share plan registration (S-8). The latest, filed 1 September 2026: 8-K, officer or director change. The 10-K, the 10-Qs and the proxy statement themselves, each with a link to open it, are on the documents page.
| Filed | Form | What it was about | Period or event date | Filing |
|---|---|---|---|---|
| 1 September 2026 | 8-K | Officer or director change | 28 August 2026 | EDGAR |
| 11 August 2026 | 10-Q | quarterly report | 30 June 2026 | EDGAR |
| 10 August 2026 | 8-K | Results of operations | 10 August 2026 | EDGAR |
| 15 July 2026 | 8-K | Other events | 15 July 2026 | EDGAR |
| 8 May 2026 | 10-Q | quarterly report | 31 March 2026 | EDGAR |
| 8 May 2026 | 8-K | Results of operations | 8 May 2026 | EDGAR |
| 20 April 2026 | S-8 | employee share plan registration | EDGAR | |
| 20 April 2026 | 8-K | Charter or bylaw amendment, or fiscal year change, Other events | 20 April 2026 | EDGAR |